Home
About Us
Our Science
News and Events
Careers
Contact
Select Page
NIA Small Business Showcase: Allyx Therapeutics, Inc.
by
mike
|
Jun 15, 2022
|
News
|
0 comments
Search
Search
Recent Posts
Allyx Therapeutics Announces Successful Completion of Two Additional Studies of Lead Candidate ALX-001
Allyx Therapeutics Awarded $3.3 Million NIH Grant to Support Further Clinical Studies of Lead Candidate ALX-001
Allyx Therapeutics Announces First Parkinson’s Disease Patient Treated with ALX-001
Neurology Live: Synapse-Targeting Agent ALX-001 Ready for Phase 2 Following Early-Stage ProgressNeurology Live: on First Patient Treated
Allyx Therapeutics Announces First Alzheimer’s Disease Patient Treated with Lead Compound ALX-001